本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Syros Pharmaceuticals Inc.

0.0924
+0.015920.78%
盘后0.0820-0.0104-11.26%19:59 EDT
成交量:8,131.85万
成交额:889.62万
市值:247.93万
市盈率:-0.03
高:0.1275
开:0.0800
低:0.0765
收:0.0765
数据加载中...
2025/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/10

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/10

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/10

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/10

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/10

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/10

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/10

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/10

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/10

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/10

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/10

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/10

自愿退市

Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
2025/03/05

重要事件披露

Form 8-K - Current report
2025/02/28

重要事件披露

Form 8-K - Current report